Drugs / SPARC1103
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02027025 Comparator | Apr 2014 → Apr 2017 | — | Sun Pharma Advanced Research Company Limited | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPARC 1103 | “The subjects will receive SPARC 1103 low dose” NCT02027025 ↗ |